The first large study of pregnancy outcomes among women with childhood-onset systemic lupus erythematosus (cSLE) demonstrates a high incidence of stillbirths and spontaneous abortions. These data are similar in women with adult-onset SLE.
Recently, investigators demonstrated the feasibility of gathering data on several key gout treatment quality indicators from EMRs. Using 10 quality indicators for gout care established more than a dozen years ago, they found that although some quality indicators are easy to assess with EMRs, others are difficult.
A retrospective chart review paints a glowing portrait of the effects of belimumab in patients with systemic lupus erythematosus (SLE). The biologic medication was associated with significant reduction in disease severity and glucocorticoid dose, according to the researchers.
A retrospective chart review paints a glowing portrait of the effects of belimumab in patients with systemic lupus erythematosus (SLE). The biologic medication was associated with significant reduction in disease severity and glucocorticoid dose, according to the researchers.
A pair of posters presented at this year’s Canadian Rheumatology Association Annual Scientific Meeting suggest that rheumatologic diseases are associated with proximity to major industrial emitters and exposure to sources of fine particulate matter air pollution.
Several types of exercise regimens are useful in the management of juvenile idiopathic arthritis (JIA), according to a new review of the literature. A group from the University of Ottawa conducted a systematic literature search for nonpharmaceutical interventions that yielded 4 high-quality, randomized, controlled trials.
Certain statins may have the potential to reduce people’s risk of developing rheumatoid arthritis (RA), according to a case-control analysis presented at the Canadian Rheumatology Association’s 2015 Annual Scientific Meeting.
A new analysis points to lower rates of breast, ovarian, and uterine cancers in patients with systemic lupus erythematosus (SLE) who were diagnosed before age 40 years compared with expected rates in the general population.
A new study confirms that people with rheumatoid arthritis (RA) have a higher risk of developing diabetes mellitus (DM) compared with the general population.
Whistler, BC—Rituximab plus methotrexate is well tolerated in patients with moderate-to-severe, active rheumatoid arthritis (RA) who take the medications for up to 11 years, according to recent research.
Page 1 of 2
Results 1 - 10 of 12
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology